Watanabe K, Yamamoto I, Yoshimura H
Eur J Pharmacol. 1983 Oct 28;94(3-4):349-51. doi: 10.1016/0014-2999(83)90427-2.
Tolerance developed to the cataleptogenic effects of delta 8-tetrahydrocannabinol (delta 8-THC) and 11-hydroxy-delta 8-THC on daily administration (5 mg/kg per day i.v.) of these substances in mice. Reciprocal cross-tolerance was also demonstrated between both cannabinoids. The ED50S (mg/kg i.v.) for delta 8-THC and 11-hydroxy-delta 8-THC were 13.0 (10.2-16.5) and 5.3 (3.4-8.2), respectively, in delta 8-THC-tolerant mice (7 days' treatment) while the corresponding ED50S were 20.8 (17.6-24.5) and 11.7 (8.5-15.7), respectively, in 11-hydroxy-delta 8-THC-tolerant mice. These values were much higher than those in the vehicle-treated mice [delta 8-THC, 4.1 (2.8-5.9); 11-hydroxy-delta 8-THC, 0.98 (0.53-1.81)].
对给予小鼠每日静脉注射这些物质(5毫克/千克/天)时,δ8-四氢大麻酚(δ8-THC)和11-羟基-δ8-THC的致僵效应产生了耐受性。两种大麻素之间也表现出交叉耐受性。在δ8-THC耐受小鼠(7天治疗)中,δ8-THC和11-羟基-δ8-THC的半数有效剂量(静脉注射毫克/千克)分别为13.0(10.2 - 16.5)和5.3(3.4 - 8.2),而在11-羟基-δ8-THC耐受小鼠中,相应的半数有效剂量分别为20.8(17.6 - 24.5)和11.7(8.5 - 15.7)。这些值远高于溶剂处理小鼠中的值[δ8-THC,4.1(2.8 - 5.9);11-羟基-δ8-THC,0.98(0.53 - 1.81)]。